Rapid growth and early crest compared to simple Rt estimate can perhaps be explained by a shortened generation interval. We observe a 2-3 day doubling, but calculating the number of secondary infections requires a generation interval assumption. 8/17
Similar values of initial epidemic growth rate r can have different values of Rt based on generation interval and lower Rt results in waves that break with fewer individual's infected. 10/17
Omicron continues to spread rapidly in the US and other countries. Here, @marlinfiggins and I estimate breakdown of Delta vs Omicron cases from genomic data from @GISAID and case counts from @OurWorldInData (further results at github.com/blab/rt-from-f…). 11/17
Some countries like the UK are farther ahead in their Omicron waves and Omicron cases have eclipsed Delta cases. Other countries like the US are just hitting the point where Omicron begins to rapidly increase overall case counts. 12/17
Omicron wave across the US and other Western countries will be difficult to track over the next 11 days to Jan 3 because of holiday under-reporting due to decreased test seeking, decreased testing capacity and delays in reporting. 13/17
More detailed estimates of severity have now come in with @mrc_outbreak estimating perhaps a 30% reduction in intrinsic severity, ie hazard ratio for hospitalization of unvaccinated Omicron case relative to unvaccinated Delta case (imperial.ac.uk/mrc-global-inf…). 14/17
With Omicron cases being primarily reinfections or breakthrough infections the overall severity in terms of risk of hospitalization is perhaps 3X lower for an Omicron case than for a Delta case. This number will differ by region based on population immunity. 15/17
So far London daily hospital admissions have been lower in absolute terms during this wave than the winter 2020-2021 wave, but are exceeding daily hospital admissions for the Delta wave (coronavirus.data.gov.uk/details/health…). 16/17
To summarize, Omicron wave will be fast and intense across geographies, but is expected to burn through quickly. Even if individual potential of severe outcomes are lower for Omicron, regions with already strained hospital capacity are particularly at risk. 17/17
Follow up #1: In tweets 6 and 7 I use estimate of 7.5% of London with reported Omicron and multiply by assumed under-reporting to arrive at 30-38% of London with Omicron infection. However, the 7.5% is 3X too high due to bug as described here:
Follow up #2: According to coronavirus.data.gov.uk/details/cases?… there were 280,317 cases (Omicron and otherwise) in London from Dec 1 to Dec 20. Based on population of 8.982 million, this is 3.1% cumulative cases (which won't all be Omicon).
Follow up #3: Correcting this error to give 3X lower cumulative cases would suggest total Omicron infections in London to be more like 10% rather than 30%. I apologize for the confusion.
Follow up #4: Tweet 7 quoting 30% of London having been infected with Omicron was being shared outside of context of thread that includes correction. I've deleted this tweet to hopefully reduce confusion.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
An update on Omicron epidemic dynamics and where we stand today. Exponential growth cannot go on forever, but predicting when a wave will crest ahead of observing slowing in case growth is very difficult. 1/17
That said, we have a fundamental prediction from basic epidemic modeling that epidemics with higher initial Rt (number of secondary infections caused by one infection) should result in larger epidemic waves in terms of total infections. 2/17
Estimates of initial Omicron Rt of ~3.5 suggested the potential for a very large wave in terms of cases, with significantly more cases than Delta wave just based on comparison of initial Rt. 3/17
I fully agree that the single best action individuals (and governments) can be taking to reduce impact of the Omicron wave is to get booster dose if already vaccinated and to get vaccinated if not. 1/14
However, I absolutely think we need to be moving forward with clinical trials for a possible future swap to an Omicron-specific or bivalent vaccine (nytimes.com/2021/12/20/hea…). 2/14
Given rapid spread there's no possibility of having an Omicron-specific vaccine ahead of the wave, and a booster with the original formulation is shown to produce good neutralization titers against Omicron and largely restore effectiveness against symptomatic disease. 3/14
The extremely rapid rate of spread of Omicron clearly visible since the beginning of December will now be acutely felt in many geographies as local epidemics amplify to the point of eclipsing Delta circulation. 1/12
Continuing previous methods, if we partition case counts from @OurWorldInData using sequence data from @GISAID and apply a modeling approach from @marlinfiggins we get rapid rises in Omicron cases in South Africa, Denmark, Germany, the UK and the US. 2/12
This corresponds to rates epidemic doubling of between 2.3 days in the UK and 3.3 days in Germany. 3/12
It seems that the common assumption has been that Omicron will displace Delta, just as Delta displaced Alpha, Beta, Gamma, etc... before it. This may well be the case, but it's by no means definite. 1/15
Depending on Omicron's mix of intrinsic transmissibility and immune escape (and what happens with continued evolution), we could see: 1. Displacement of Delta by Omicron 2. Long-term co-circulation 3. Omicron wave followed by resurgence of Delta and extinction of Omicron
2/15
Intuitively, the more immune escape Omicron has from Delta-specific immunity the more the two variants have distinct ecological niches and so are able to co-exist without stepping on each other's toes. 3/15
There is now enough genomic data from the US and Germany to repeat this approach to estimating Omicron-specific rate of epidemic spread. Here, we observe similar initial rapid spread in the US and Germany. 1/10
As before, we partition case counts from @OurWorldInData using sequences from @GISAID into estimated Omicron, Delta and other cases, and we use this partitioning to infer variant-specific Rt and epidemic growth rate r (methods and code here github.com/blab/rt-from-f…). 2/10
We find that logistic growth of Omicron sequence fraction looks similar between the UK, the US and Germany with roughly 1% of sequenced cases in all three countries being Omicron on Dec 1. 3/10
We've seen exceptionally rapid spread of Omicron in South Africa. Although we should expect this rapid spread to follow in other geographies, we've mostly lacked data to confirm this until recently. 1/21
) and extremely strong genomic surveillance by @CovidGenomicsUK, we should have early data from the UK about rate of spread outside of South Africa. 2/21
The UK is sequencing between 5000 and 8000 viruses everyday. Although turnaround times are fast, necessary processing delays permit a view that's basically lagged by ~7 days. Today, I have a strong view of Dec 1 data in @GISAID, but Dec 2 has much less data available to me. 3/21